NeoChord Names J. Alex Martin Chairman of the Board ST.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
88
NeoChord Names J. Alex Martin Chairman of the Board

ST. LOUIS PARK, Minn., Jan. 23, 2017 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative mitral regurgitation (DMR), today announced the appointment of J. Alex Martin, who currently serves as a director on the Company’s Board, as Board Chairman, effective immediately.  Michael Fulton, M.D., the Company’s current Board Chairman, will remain as an integral member of the Board of Directors.

“Alex has over 40 years of experience in the healthcare and medical device industries, and I am delighted that NeoChord can further benefit from his leadership in his new role as Board Chairman,” said David Chung, President and Chief Executive Officer of NeoChord. “His proven executive experience and track record in high growth organizations will be invaluable to NeoChord as we continue to advance our strategic objectives. In prior roles, Alex has been instrumental in driving business development activities and broad corporate growth. I also would like to thank Dr. Fulton for his many contributions and direction as Board Chairman, including his role as Interim CEO, while leading the CEO search committee in 2014. We look forward to his future contributions as a director and greatly appreciate his continued dedication and commitment to NeoChord.”

“I am pleased to continue working alongside the company’s outstanding management team and my fellow board members,” said Alex Martin. “I deeply believe in NeoChord’s mission and am very encouraged that their new off-pump approach provides a significant solution for a disease that currently can only be addressed with more invasive bypass pump surgery.”

Mr. Martin has significant corporate executive of the healthcare and medical device industries experience. He previously served as the President and CEO of Coherex Medical, where he led the company to a successful exit with Biosense Webster, a Johnson and Johnson company, in November 2015. Prior to Coherex, Mr. Martin was the President and CEO of WorldHeart Corporation, where he led the company to a successful exit with HeartWare in August 2012. Previously, Mr. Martin has held senior leadership roles with Edwards Lifesciences, Cordis Corporation, a Johnson & Johnson Company, and SonaMed Corporation. Mr. Martin holds a bachelor’s degree from the University of Kentucky.

About NeoChord, Inc.

Founded in 2007 and based in St. Louis Park, Minnesota, NeoChord, Inc. is a privately held medical technology company leading the advancement of minimally invasive repair for DMR. NeoChord’s DS1000 system received CE market clearance in December 2012. NeoChord received IDE approval from the FDA for the US pivotal trial in May 2016. For more information, please visit the Company's website at  www.neochord.com .

The NeoChord DS1000 System is CE marked and approved for sale in Europe.  CAUTION: Investigational Device Limited by Federal (United States) Law to Investigational Use.

NeoChord, DS1000, ReChord, and the stylized logo are trademarks of NeoChord Corporation.

Contact: Bruce Van Deman NeoChord, Inc. (952) 698-7812 or (949) 413-1301 bvandeman@neochord.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

GeeLark's Mobile-Cloud Push Redefines Social Media Ops

Updated Category News Views 8

Riding the Mobile Wave: A New Era in Digital Marketing Folks, GeeLark's latest move is like a sledgehammer to an old wall. Smashed it with their recent rollout of a unified Browser and Cloud Phone platform. This isn't just upgrading the toolbox—it's overhauling the whole workshop. As someone who's seen enough tech promises fizzle, this one might actually stick....

Continue Reading
Seven & i Holdings Expands Convenience Store Footprint Across North America

Updated Category News Views 377

Seven & i Holdings Plans Major Expansion in North America Japan's Seven & i Holdings has unveiled its ambitious plan to establish 500 new convenience stores in the United States and Canada by 2027. This strategic move comes as the company seeks to solidify its presence in the North American market and compete against local and international convenience store chains....

Continue Reading
How Russia Has Embraced Bitcoin Amidst Economic Challenges

Updated Category News Views 212

Bitcoin's Enduring Presence in Russia Not long ago, Russian President Vladimir Putin took a bold stance by declaring that Bitcoin could not be banned, regardless of any attempts by governments around the globe. This declaration underscored a potential shift in the country's approach to cryptocurrency amidst the backdrop of escalating international sanctions. Putin's...

Continue Reading
Jumptuit Receives USPTO Allowance for Innovative AI Patent

Updated Category News Views 363

Jumptuit's Progress in Artificial Intelligence Technology Jumptuit, a prominent company in the field of AI research and development, has recently marked a significant milestone in its innovative journey. The U.S. Patent and Trademark Office (USPTO) has granted Jumptuit a Notice of Allowance, enhancing its protection for cutting-edge AI Search Technology. This development...

Continue Reading
Harbour BioMed Unveils Promising Results for HBM1020

Updated Category News Views 110

Harbour BioMed Shares Exciting Results for HBM1020 Harbour BioMed, a global biopharmaceutical company dedicated to creating groundbreaking antibody therapeutics, has reached significant milestones in its clinical research. The company recently shared incredible clinical data on HBM1020, a first-of-its-kind fully human anti-B7H7/HHLA2 monoclonal antibody. This information...

Continue Reading